Centre de recherche clinique Étienne-Le Bel du CHUS
Sherbrooke, Quebec, J1H 5N4, Canada
NCT Number: NCT00444899
Worldwide, health systems and practitioners are facing obesity epidemics. High blood pressure, dyslipidemia and diabetes prevalence will explode during the 21st century.
The two main objectives of this 2-year controlled prospective study are:
1. to demonstrate that, for patients with high blood pressure, diabetes and dyslipidemia, dietician conducted survey and management in combination with annual endocrinologist follow-up enable both attainment and maintenance of recommended blood pressure, glycemic and lipid goals, as well as smoking cessation; 2. to demonstrate that dietician management is more cost effective than conventional care provided by general practitioners and endocrinologists.
Results are expected to show significantly different cardiovascular risk profiles (BMI and waist circumference, systolic and diastolic blood pressure, LDL-C, triglycerides and Total cholesterol/HDL ratio, HbA1c, smoking) between baseline and after 2 years follow-up. Sample size was determined in order to show statistically significant differences between the two groups.
Results will document for the benefit of care givers, health economists and policy makers alike an innovative and integrated model of care which is expected to be effective at the patient level as well as cost effective with respect to the increasing financial burden of diabetes on the health system.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Sherbrooke, Quebec, J1H 5N4, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Subjects will be followed by the dietician in combination with his/her endocrinologist. Diet, physical activity, smoking cessation and drug prescriptions will be used to treat subjects.
Subject will continue to be followed by their endocrinologist and general practitioner as they already do.
Time frame: 36 months
Time frame: 36 months
Time frame: 36 months
Université de Sherbrooke
Other
Clinical and Economic Benefits of Cardiovascular Risk Management by a Dietician in Diabetic Patients
Acronym: GRC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05229718
Autoimmune Diseases, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT07403565
Autoimmune Diseases, Diabetes Mellitus
Beijing, Beijing Municipality, China
View Trial DetailsNCT06418880
Autoimmune Diseases, Diabetes Mellitus
Stanford, California, United States
View Trial DetailsNCT05893797
Autoimmune Diseases, Diabetes Mellitus
Strasbourg, Alsace, France
View Trial Details